477 related articles for article (PubMed ID: 17975474)
1. Molecular mechanisms of increased intrahepatic resistance in portal hypertension.
Shah V
J Clin Gastroenterol; 2007; 41 Suppl 3():S259-61. PubMed ID: 17975474
[TBL] [Abstract][Full Text] [Related]
2. Vascular deterioration in cirrhosis: the big picture.
Bosch J
J Clin Gastroenterol; 2007; 41 Suppl 3():S247-53. PubMed ID: 17975472
[TBL] [Abstract][Full Text] [Related]
3. Pathophysiology of portal hypertension.
Cichoz-Lach H; Celiński K; Słomka M; Kasztelan-Szczerbińska B
J Physiol Pharmacol; 2008 Aug; 59 Suppl 2():231-8. PubMed ID: 18812641
[TBL] [Abstract][Full Text] [Related]
4. Hemodynamics in the isolated cirrhotic liver.
Zipprich A
J Clin Gastroenterol; 2007; 41 Suppl 3():S254-8. PubMed ID: 17975473
[TBL] [Abstract][Full Text] [Related]
5. [Pathophysiology of portal hypertension, what's new?].
Kim MY; Baik SK
Korean J Gastroenterol; 2010 Sep; 56(3):129-34. PubMed ID: 20847603
[TBL] [Abstract][Full Text] [Related]
6. Nitroflurbiprofen, a nitric oxide-releasing cyclooxygenase inhibitor, improves cirrhotic portal hypertension in rats.
Laleman W; Van Landeghem L; Van der Elst I; Zeegers M; Fevery J; Nevens F
Gastroenterology; 2007 Feb; 132(2):709-19. PubMed ID: 17258737
[TBL] [Abstract][Full Text] [Related]
7. [Pathogenesis of portal hypertension].
Montaño-Loza A; Meza-Junco J
Rev Invest Clin; 2005; 57(4):596-607. PubMed ID: 16315644
[TBL] [Abstract][Full Text] [Related]
8. Causes and pathomechanisms of oesophageal varices development.
Paquet KJ
Med Sci Monit; 2000; 6(5):915-28. PubMed ID: 11208432
[TBL] [Abstract][Full Text] [Related]
9. Regulation of sinusoidal perfusion in portal hypertension.
Reynaert H; Urbain D; Geerts A
Anat Rec (Hoboken); 2008 Jun; 291(6):693-8. PubMed ID: 18484616
[TBL] [Abstract][Full Text] [Related]
10. Hemodynamic alterations in cirrhosis and portal hypertension.
Kim MY; Baik SK; Lee SS
Korean J Hepatol; 2010 Dec; 16(4):347-52. PubMed ID: 21415576
[TBL] [Abstract][Full Text] [Related]
11. Hemodynamic changes in splanchnic blood vessels in portal hypertension.
Colle I; Geerts AM; Van Steenkiste C; Van Vlierberghe H
Anat Rec (Hoboken); 2008 Jun; 291(6):699-713. PubMed ID: 18484617
[TBL] [Abstract][Full Text] [Related]
12. Pathophysiology of portal hypertension.
Bosch J; Pizcueta P; Feu F; Fernández M; García-Pagán JC
Gastroenterol Clin North Am; 1992 Mar; 21(1):1-14. PubMed ID: 1568769
[TBL] [Abstract][Full Text] [Related]
13. Nitric oxide and portal hypertension: its role in the regulation of intrahepatic and splanchnic vascular resistance.
Wiest R; Groszmann RJ
Semin Liver Dis; 1999; 19(4):411-26. PubMed ID: 10643626
[TBL] [Abstract][Full Text] [Related]
14. Molecular and structural basis of portal hypertension.
Moreau R; Lebrec D
Clin Liver Dis; 2006 Aug; 10(3):445-57, vii. PubMed ID: 17162222
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological control of portal hypertension.
Polio J; Groszmann RJ
Prog Liver Dis; 1993; 11():231-49. PubMed ID: 8272513
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological treatment of portal hypertension.
González-Abraldes J; Bosch J; García-Pagán JC
Curr Opin Investig Drugs; 2001 Oct; 2(10):1407-13. PubMed ID: 11890356
[TBL] [Abstract][Full Text] [Related]
17. Nitric oxide and portal hypertension: interface of vasoreactivity and angiogenesis.
Langer DA; Shah VH
J Hepatol; 2006 Jan; 44(1):209-16. PubMed ID: 16297493
[No Abstract] [Full Text] [Related]
18. Etiology and pathophysiology of portal hypertension.
Reichen J
Z Gastroenterol; 1988 Sep; 26 Suppl 2():3-7. PubMed ID: 3055716
[TBL] [Abstract][Full Text] [Related]
19. Role of vasoactive substances and cellular effectors in the pathophysiology of cirrhotic portal hypertension: the past, the present and the future--Georges Brohée Lecture.
Laleman W
Acta Gastroenterol Belg; 2009; 72(1):9-16. PubMed ID: 19402365
[TBL] [Abstract][Full Text] [Related]
20. Portal hypertension and blood viscosity.
Sikuler E
J Clin Gastroenterol; 2007; 41 Suppl 3():S262-5. PubMed ID: 17975475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
